Validity and reproducibility of hand-held dynamometry in children aged 4-11 years.

Contains fulltext : 51143.pdf (publisher's version ) (Open Access)OBJECTIVE: To evaluate validity and reproducibility of hand-held dynamometry in 11 different muscle groups in children. DESIGN AND PATIENTS: Maximum isometric muscle strength was measured with a calibrated hand-held dynamometer in 61 patients aged 4-11 years who had been referred to our specialist centre in the past 3 years because of suspected myopathy. All the patients had had muscle biopsy. METHODS: Validity was assessed by the power to discriminate between patients with and without myopathy, using logistic regression analysis and receiver operating characteristic analysis and sensitivity and specificity at a specifically chosen cut-off point. Reproducibility was evaluated by test-retest reliability in a stratified random sample of 40 patients who returned for re-measurements, using the intraclass correlation coefficient and the standard error of measurement. RESULTS: In the patients, areas under the receiver operating characteristic curve ranged from 0.66 to 0.88. At a specifically chosen cut-off point, sensitivity varied from 73% to 87%, while specificity varied from 54% to 80%. Intraclass correlation coefficients ranged from 0.73 to 0.91. The standard error of measurement ranged from 3.3 N to 12.2 N. CONCLUSION: Performance of hand-held dynamometry varied widely in the 11 muscle groups. Highest performance was observed in the elbow flexors. Test-retest reliability of the mean value of 2 efforts was generally higher than the maximum value

Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.

Item does not contain fulltextBACKGROUND: An excessive increase in the incidence of primary central nervous system lymphoma (PCNSL) has been reported since the mid-1980s in the U.S. and U.K. Clinical studies have shown that radiotherapy and chemotherapy may prolong survival. In the current study, the authors describe the incidence, treatment, and survival of an unselected group of patients with PCNSL in the southern and eastern Netherlands. METHODS: Data regarding patients diagnosed between 1989-1994 were obtained from 4 population-based regional cancer registries in the southern and eastern Netherlands (n = 86) and the Eindhoven Cancer Registry for 1980-1988 (n = 6). Lymphomas were registered as PCNSL when a tissue diagnosis of CNS lymphoma was established for a patient with neurologic symptoms (i.e., lymphomas were not necessarily restricted to the CNS at the time of diagnosis). Only patients diagnosed during their lifetime with Stage I disease, Stage "IV" disease (i.e., diffuse CNS lymphoma), or disease of unknown stage were included (63 patients, 8 patients, and 15 patients, respectively, between 1989-1994). For 80 patients (93%) follow-up was complete until January 1, 1997. RESULTS: Between 1989-1994, an average World Standardized Rate of 2.3 cases and 1.7 cases per 1 million person-years, respectively, was reported for males and females. The median age of the patients at the time of diagnosis was 62 years, and was 66 years for patients with an unknown disease stage. In the area of the Eindhoven Cancer Registry the occurrence of PCNSL more than doubled from or = 60 years. CONCLUSIONS: The increase in the incidence of PCNSL in the 1980s may be explained in large part by changes in diagnostics and registration. The relatively high incidence and low survival rate of PCNSL in the southern and eastern Netherlands reported in the 1990s may be due in part to the inclusion of patients with systemic lymphoma and immunodeficiency disorders. However, a significant improvement in the prognosis of patients with PCNSL in the southern and eastern Netherlands diagnosed in the 1990s is unlikely

Validity and reproducibility of the Jamar dynamometer in children aged 4-11 years.

Contains fulltext : 51144.pdf (publisher's version ) (Closed access)PURPOSE: Validity and reproducibility of the Jamar dynamometer were evaluated in children aged 4-11 years. METHOD: Hand grip strength was measured on the dominant side and non-dominant side in 67 patients who had been referred to our specialist centre in the past 3 years because of suspected myopathy. All the patients had had muscle biopsy. Sixteen out of the 67 patients proved to have myopathy, while 51 had no myopathy. The investigator was blinded against the true diagnosis and clinical course of the patients at the time of testing. Validity was assessed by the power to discriminate between patients with and without myopathy, using logistic regression analysis and receiver operating characteristic (ROC) analysis. The area under the ROC curve (AUC) was calculated as a measure of the discriminative power. Sensitivity (Se) and specificity (Sp) were assessed at a specifically chosen cut-off point. Reproducibility was assessed by evaluating the test-retest reliability in a stratified random sample of 40 patients who returned for remeasurements, using the intraclass correlation coefficient (ICC). RESULTS: AUCs ranged from 0.78 - 0.82. At an Se = 81% cut-off point, Sp varied from 67-73%. ICCs ranged from 0.91-0.93. CONCLUSIONS: The Jamar dynamometer had discriminative power in children with suspected myopathy. Reproducibility was high. The Jamar dynamometer was a good, but not completely accurate, test for myopathy

Validity and reproducibility of a new diagnostic motor performance test in children with suspected myopathy.

Contains fulltext : 51142.pdf (publisher's version ) (Closed access)To spare more children from painful muscle biopsy, a new non-invasive diagnostic motor performance test is undergoing development. Fifteen functional items were used to measure muscle strength and muscle endurance in 68 patients (47 males, 21 females; mean age 7y 8mo, SD 2y 2mo; range 4 to 11y), who had been referred to our specialist centre in the past 3 years on suspicion of myopathy. All the patients had undergone muscle biopsy. To correct the patients' outcomes for age, sex, and body size, regression prediction equations were obtained from a stratified random sample of 64 normally developing primary-school children aged 4 to 11 years (32 males, 32 females; mean age 8y 1mo, SD 2y 4mo). Feasibility was evaluated on the basis of five criteria. Validity was assessed using logistic regression analysis, receiver operating characteristic analysis, and sensitivity and specificity at a specifically chosen cut-off point. Reproducibility was evaluated by test-retest reliability in a stratified random sample of 40 patients who returned for re-measurements using the intraclass correlation coefficient. Seven items satisfied all five feasibility criteria, had high diagnostic power, and high test-retest reliability. The motor performance test can improve diagnostic procedure in children suspected of having myopathy

Development and Evaluation of an Implementation Strategy for Collecting Data in a National Registry and the Use of Patient-Reported Outcome Measures in Physical Therapist Practices: Quality Improvement Study

Item does not contain fulltextBackground: In 2013, the Royal Dutch Society for Physical Therapy launched the program "Quality in Motion." This program aims to collect data from electronic health record systems in a registry that is fed back to physical therapists, facilitating quality improvement. Purpose: The purpose of this study was to describe the development of an implementation strategy for the program and to evaluate the feasibility of building a registry and implementing patient-reported outcome measures (PROMs) in physical therapist practices. Methods: A stepwise approach using mixed methods was established in 3 consecutive pilots with 355 physical therapists from 66 practices. Interim results were evaluated using quantitative data from a self-assessment questionnaire and the registry and qualitative data from 21 semistructured interviews with physical therapists. Descriptive statistics and McNemar's symmetry chi-squared test were used to summarize the feasibility of implementing PROMs. Results: PROMs were selected for the 5 most prevalent musculoskeletal conditions in Dutch physical therapist practices. A core component of the implementation strategy was the introduction of knowledge brokers to support physical therapists in establishing the routine use of PROMs in clinical practice and to assist in executing peer assessment workshops. In February 2013, 30.3% of the physical therapist practices delivered 4.4 completed treatment episodes per physical therapist to the registry; this increased to 92.4% in November 2014, delivering 54.1 completed patient episodes per physical therapist. Pre- and posttreatment PROM use increased from 12.2% to 39.5%. Limitations: It is unclear if the participating physical therapists reflect a representative sample of Dutch therapists. Conclusion: Building a registry and implementing PROMs in physical therapist practices are feasible. The routine use of PROMs needs to increase to ensure valid feedback of outcomes. Using knowledge brokers is promising for implementing the program via peer assessment workshops

Comparison of 3 instruments to measure muscle strength in children: A prospective study

Item does not contain fulltextAIM: To establish which instrument is the most valid and reliable measure of muscle strength in children aged 4-11 years and can improve the diagnostic procedure in children with suspected myopathy to spare more of them from muscle biopsy. METHODS: In a prospective study over a 2 year period, 22 patients aged 4-11 years were recruited. They had all been referred to our specialist centre on the suspicion of myopathy. Hand-held dynamometry, the Jamar dynamometer and a new Motor Performance Test were administered before muscle biopsy. Validity was assessed by the power to discriminate between patients with and without myopathy using logistic regression analysis and receiver operating characteristic (ROC) analysis. The area under the ROC curve (AUC) was calculated as a measure of the diagnostic power. RESULTS: Comparison of the three instruments showed that the Motor Performance Test had the highest validity. Hand-held dynamometry generally had lower validity and showed wide variation in the 11 muscle groups. The Jamar dynamometer had very low validity in early stage myopathy. CONCLUSION: The Motor Performance Test was the most valid and reliable instrument to indicate the presence of myopathy in children. This objective, non-invasive and child-friendly instrument can improve the diagnostic procedure and exclude more children without myopathy from muscle biopsy

Impact of Self- and Peer Assessment on the Clinical Performance of Physiotherapists in Primary Care: A Cohort Study

Item does not contain fulltex

A new motor performance test in a prospective study on children with suspected myopathy.

Contains fulltext : 51237.pdf (publisher's version ) (Closed access)In the development of a new diagnostic motor performance test to spare more children from painful muscle biopsy, seven functional items were used to measure muscle strength and muscle endurance in a prospective study on new patients. Over a 2-year period, 22 patients (12 males, 10 females; mean age 8y 1mo [SD 2y 6mo], range 4-11y) were recruited for the study. They had all been referred with suspected myopathy. The motor performance test was administered before muscle biopsy. Validity of the seven items was assessed using logistic regression analysis and receiver operating characteristic (ROC) analysis. Two items were withdrawn from the test because they were not suitable for children aged 4 to 5 years. The five remaining items were: Heels, Circuit, Stairs, Jump, and Gowers. A full logistic regression model including these five items was fitted to the total population of 90 patients suspected of having myopathy (from this study and our previous study) to make the best prediction of whether myopathy was present. The ROC area under the curve of the diagnostic prediction model was 0.92 (95% confidence interval [CI] 0.87-0.98) and 0.89 (95% CI 0.87-0.92) after bootstrap correction. This indicated the high diagnostic power that can be expected for future, similar patients. This non-invasive and child-friendly motor performance test can improve diagnostic procedure and, therefore, spare more children from unnecessary muscle biopsy